ALMS

COM:ALUMIS

Alumis

  • Stock

Last Close

10.35

20/11 21:00

Market Cap

668.34M

Beta: -

Volume Today

244.99K

Avg: -

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Biotechnology
  • website

    alumis.com
  • linkedin

    alumis-co
  • founding date

    Jan 01, 2021
  • ipo date

    Feb 22, 2021

Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. It develops ESK-001, an allosteric tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis, systemic lupus erythematosus, and non-infectious uveitis; and A-005, a central nervous system-penetrant allosteric TYK2 inhibi...Show More

investor of